Condition
MNGIE
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting2
Enrolling By Invitation1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT05554835Recruiting
Global Registry and Natural History Study for Mitochondrial Disorders
NCT07627217RecruitingPrimary
MNGIE Natural History Study
NCT01803906Enrolling By Invitation
Tissue Sample Study for Mitochondrial Disorders
NCT05658822UnknownPrimary
Digestive Dysmotility in Mitochondrial Neurogastrointestinal Encephalomyopathy
Showing all 4 trials